The Chamber of Commerce for Greater Philadelphia commissioned a study conducted by Econsult Solutions, Inc., titled The State of Cell and Gene Therapy in the Greater Philadelphia Region: A Comparative Analysis, which measured the impact of our region’s progress in cell and gene therapy through five key lenses: research infrastructure, human capital, innovation output, commercial activity, and value proposition. The study compared Greater Philadelphia to 14 other U.S. metros – Baltimore, Boston, Chicago, Cleveland, Houston, Indianapolis, Los Angeles, New York, Research Triangle, San Diego, San Francisco, Seattle, and Washington D.C. – […]
The CEO Council was pleased to again contribute to Big4Bio’s annual 2021 Philadelphia Year-in-Review report by providing a look forward to what we might expect in the region’s life sciences industry, including the cell and gene therapy sector, in 2022. The outlook is reprinted below and the link to the full report, as well as reports for the Boston, San Francisco Bay, and San Diego markets, can be found on Big4Bio’s website.
“These Year-in-Reviews reflect the constant growth of the life science industry in these Big4Bio regions and also help provide important information for 2022 planning […]
Study Projects Future Workforce Talent Needs for Cell & Gene Therapy Sector and Benchmarks Connected Health Sector in Greater Philadelphia
PHILADELPHIA (May 13, 2020) – An independent study to analyze the current workforce landscape and assess the future talent needs of the Greater Philadelphia region’s cell and gene therapy and connected health sectors has found that this workforce is expected to grow between 35 percent to 94 percent in the next 10 years using mid-range growth estimates. The growth could be as much as 54 percent to 136 percent using high-range growth estimates.
With support from The Lenfest Foundation, three organizations – the Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth, the University City Science Center, and University […]